Cumberland Pharmaceuticals (CPIX) vs Eton Pharmaceuticals (ETON)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Eton Pharmaceuticals (ETON) has outperformed Cumberland Pharmaceuticals (CPIX) over the past year, gaining 161.6% versus a gain of 90.2%. Over five years, ETON leads with a +950.9% price change compared with +154.7% for CPIX. Eton Pharmaceuticals is the larger company by market cap ($1.56 billion vs $104.6 million), about 15.0 times the size.
On valuation, Eton Pharmaceuticals trades at a lower forward P/E (21.2x vs 49.9x for Cumberland Pharmaceuticals).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CPIX | ETON |
|---|---|---|
| Share price | $6.98 | $54.75 |
| Market cap | $104.58M | $1.56B |
| 1-day change | +1.31% | -0.24% |
| YTD return | +75.38% | +223.77% |
| 1-year return | +90.19% | +161.59% |
| 5-year return | +154.74% | +950.86% |
| P/E ratio (TTM) | — | 136.88 |
| Forward P/E | 49.86 | 21.22 |
| EPS (TTM) | $-0.62 | $0.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $79.95M |
| Revenue growth (YoY) | — | +104.94% |
| Net income (latest FY) | — | $-4.60M |
| Gross margin | — | 53.46% |
| Operating margin | — | -1.06% |
| Net margin | — | -5.75% |
| 52-week high | $9.28 | $66.37 |
| 52-week low | $1.85 | $14.27 |
| Distance from 52-week high | -24.78% | -17.51% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +29.68% |
| Average volume | 87.71K | 609.36K |
| Shares outstanding | 14.98M | 28.58M |
| Employees | 88 | 44 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Eton Pharmaceuticals is about 15.0 times larger than Cumberland Pharmaceuticals by market value ($1.56B vs $104.58M).
- ETON has outperformed CPIX by 71.4 percentage points over the past year.
About Cumberland Pharmaceuticals
CPIX stock →Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H.
Healthcare · Drug Manufacturers - Specialty & Generic · 88 employees
About Eton Pharmaceuticals
ETON stock →Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1.
Healthcare · Drug Manufacturers - Specialty & Generic · 44 employees
CPIX vs ETON FAQ
Which is bigger, Cumberland Pharmaceuticals or Eton Pharmaceuticals?
Eton Pharmaceuticals (ETON) is larger, with a market capitalization of $1.56B compared with $104.58M for Cumberland Pharmaceuticals (CPIX).
Which stock has performed better over the past year, CPIX or ETON?
ETON returned +161.59% over the past 12 months, compared with +90.19% for CPIX (price return, excluding dividends). Past performance does not predict future results.
Are Cumberland Pharmaceuticals and Eton Pharmaceuticals in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.